Anti-obesity drugs such as Ozempic were the "breakthrough of the year" in 2023, according to the AAAS journal Science. Overweight and obesity rates are rising worldwide, with several Latin American countries in the forefront. Estimates for 2020 pointed to a global obesity rate of 14%, and experts predicted 24% by 2035, including both adults and children.